BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11827245)

  • 1. Diabetes mellitus. Medication update.
    Slagle M
    South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245
    [No Abstract]   [Full Text] [Related]  

  • 2. Seeking sweet relief for diabetes.
    Dove A
    Nat Biotechnol; 2002 Oct; 20(10):977-81. PubMed ID: 12355109
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 2 diabetes management: a comprehensive clinical review of oral medications.
    Quillen DM; Kuritzky L
    Compr Ther; 2002; 28(1):50-61. PubMed ID: 11894443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapy with biguanides].
    Sakura H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
    [No Abstract]   [Full Text] [Related]  

  • 5. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 2 diabetes therapy. A pathophysiologically based approach.
    Mayerson AB; Inzucchi SE
    Postgrad Med; 2002 Mar; 111(3):83-4, 87-92, 95. PubMed ID: 11912999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
    Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacologic treatment of diabetes].
    De Montigny P; Clerc C; Descarpentries C
    Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments and devices for future diabetes management.
    Capaldi B
    Nurs Times; 2005 May 3-9; 101(18):30-2. PubMed ID: 15892503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of noninsulin antidiabetic medications in hospitalized patients.
    Kopecky C
    Crit Care Nurs Clin North Am; 2013 Mar; 25(1):39-53. PubMed ID: 23410645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of diabetes mellitus.
    Mozersky RP
    J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral agents in the management of type 2 diabetes mellitus.
    Luna B; Feinglos MN
    Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of type 2 diabetes. Evolving strategies for treatment.
    Umpierrez GE; Kitabchi AE
    Obstet Gynecol Clin North Am; 2001 Jun; 28(2):401-19, viii. PubMed ID: 11430184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 17. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
    Bloomgarden ZT
    Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rosiglitazone: clinical data].
    Blickle JF
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes.
    Bianchi C; Miccoli R; Daniele G; Penno G; Del Prato S
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S342-8. PubMed ID: 19875578
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.